Topics

Articles

PhRMA is critical of basing coinsurance or deductibles on drugs’ list prices

5.4-million-member BCBS Federal Employee Program (FEP) is moving

Scott Gottlieb, a former FDA and CMS executive, brings an experienced hand

Initial plans include having a ‘seat at the table’ in PBM formulary discussions

Rare-disease drug also garnered a valuable pediatric review voucher

GPhA rebrands and aligns more closely with biosimilars

Humana-Aetna merger is off; Anthem-Cigna likely to follow

'Rebates do not raise drug prices, drug makers do,' says the PBM